169 related articles for article (PubMed ID: 22814225)
1. Single-pass intestinal perfusion to establish the intestinal permeability of model drugs in mouse.
Escribano E; Sala XG; Salamanca J; Navarro CR; Regué JQ
Int J Pharm; 2012 Oct; 436(1-2):472-7. PubMed ID: 22814225
[TBL] [Abstract][Full Text] [Related]
2. Prediction of human absorption of a trioxane antimalarial drug (CDRI 99/411) using an in-house validated in situ single-pass intestinal perfusion model.
Wahajuddin ; Singh SP; Patel K; Pradhan T; Siddiqui HH; Singh SK
Arzneimittelforschung; 2011; 61(9):532-7. PubMed ID: 22029231
[TBL] [Abstract][Full Text] [Related]
3. The utility of rat jejunal permeability for biopharmaceutics classification system.
Zakeri-Milani P; Valizadeh H; Tajerzadeh H; Islambulchilar Z
Drug Dev Ind Pharm; 2009 Dec; 35(12):1496-502. PubMed ID: 19929209
[TBL] [Abstract][Full Text] [Related]
4. Biopharmaceutical classification of drugs using intrinsic dissolution rate (IDR) and rat intestinal permeability.
Zakeri-Milani P; Barzegar-Jalali M; Azimi M; Valizadeh H
Eur J Pharm Biopharm; 2009 Sep; 73(1):102-6. PubMed ID: 19442726
[TBL] [Abstract][Full Text] [Related]
5. Predicting human intestinal permeability using single-pass intestinal perfusion in rat.
Zakeri-Milani P; Valizadeh H; Tajerzadeh H; Azarmi Y; Islambolchilar Z; Barzegar S; Barzegar-Jalali M
J Pharm Pharm Sci; 2007; 10(3):368-79. PubMed ID: 17727800
[TBL] [Abstract][Full Text] [Related]
6. In-situ intestinal rat perfusions for human Fabs prediction and BCS permeability class determination: Investigation of the single-pass vs. the Doluisio experimental approaches.
Lozoya-Agullo I; Zur M; Wolk O; Beig A; González-Álvarez I; González-Álvarez M; Merino-Sanjuán M; Bermejo M; Dahan A
Int J Pharm; 2015 Mar; 480(1-2):1-7. PubMed ID: 25595387
[TBL] [Abstract][Full Text] [Related]
7. The suitability of an in situ perfusion model for permeability determinations: utility for BCS class I biowaiver requests.
Kim JS; Mitchell S; Kijek P; Tsume Y; Hilfinger J; Amidon GL
Mol Pharm; 2006; 3(6):686-94. PubMed ID: 17140256
[TBL] [Abstract][Full Text] [Related]
8. Frog intestinal sac as an in vitro method for the assessment of intestinal permeability in humans: Application to carrier transported drugs.
Franco M; Lopedota A; Trapani A; Cutrignelli A; Meleleo D; Micelli S; Trapani G
Int J Pharm; 2008 Mar; 352(1-2):182-8. PubMed ID: 18055143
[TBL] [Abstract][Full Text] [Related]
9. A Sensitive Medium-Throughput Method to Predict Intestinal Absorption in Humans Using Rat Intestinal Tissue Segments.
Da Silva LC; Da Silva TL; Antunes AH; Rezende KR
J Pharm Sci; 2015 Sep; 104(9):2807-12. PubMed ID: 25690454
[TBL] [Abstract][Full Text] [Related]
10. Comprehensive study on regional human intestinal permeability and prediction of fraction absorbed of drugs using the Ussing chamber technique.
Sjöberg Å; Lutz M; Tannergren C; Wingolf C; Borde A; Ungell AL
Eur J Pharm Sci; 2013 Jan; 48(1-2):166-80. PubMed ID: 23103351
[TBL] [Abstract][Full Text] [Related]
11. Theoretical investigation of passive intestinal membrane permeability using Monte Carlo method to generate drug-like molecule population.
Sugano K
Int J Pharm; 2009 May; 373(1-2):55-61. PubMed ID: 19429288
[TBL] [Abstract][Full Text] [Related]
12. Intestinal permeability of forskolin by in situ single pass perfusion in rats.
Liu ZJ; Jiang DB; Tian LL; Yin JJ; Huang JM; Weng WY
Planta Med; 2012 May; 78(7):698-702. PubMed ID: 22411728
[TBL] [Abstract][Full Text] [Related]
13. Segmental-dependent membrane permeability along the intestine following oral drug administration: Evaluation of a triple single-pass intestinal perfusion (TSPIP) approach in the rat.
Dahan A; West BT; Amidon GL
Eur J Pharm Sci; 2009 Feb; 36(2-3):320-9. PubMed ID: 19028572
[TBL] [Abstract][Full Text] [Related]
14. Investigation of the intestinal permeability and first-pass metabolism of drugs in cynomolgus monkeys using single-pass intestinal perfusion.
Takahashi M; Washio T; Suzuki N; Igeta K; Yamashita S
Biol Pharm Bull; 2010; 33(1):111-6. PubMed ID: 20045946
[TBL] [Abstract][Full Text] [Related]
15. Comparison of two approaches of intestinal absorption by puerarin.
Li H; Dong L; Liu Y; Wang G; Zhang L; Qiao Y
J Pharmacol Toxicol Methods; 2014; 70(1):6-11. PubMed ID: 24674709
[TBL] [Abstract][Full Text] [Related]
16. Development of an in vitro rat intestine segmental perfusion model to investigate permeability and predict oral fraction absorbed.
Castella ME; Reist M; Mayer JM; Turban JJ; Testa B; Boursier-Neyret C; Walther B; Delbos JM; Carrupt PA
Pharm Res; 2006 Jul; 23(7):1543-53. PubMed ID: 16779709
[TBL] [Abstract][Full Text] [Related]
17. Biopharmaceutics classification and intestinal absorption study of apigenin.
Zhang J; Liu D; Huang Y; Gao Y; Qian S
Int J Pharm; 2012 Oct; 436(1-2):311-7. PubMed ID: 22796171
[TBL] [Abstract][Full Text] [Related]
18. High-permeability criterion for BCS classification: segmental/pH dependent permeability considerations.
Dahan A; Miller JM; Hilfinger JM; Yamashita S; Yu LX; Lennernäs H; Amidon GL
Mol Pharm; 2010 Oct; 7(5):1827-34. PubMed ID: 20701326
[TBL] [Abstract][Full Text] [Related]
19. Simultaneous determination of nine model compounds in permeability samples using RP-HPLC: application to prove the cassette administration principle in single pass intestinal perfusion study in rats.
Wahajuddin ; Singh SP; Raju KS; Nafis A; Jain GK
J Pharm Biomed Anal; 2012; 67-68():71-6. PubMed ID: 22613582
[TBL] [Abstract][Full Text] [Related]
20. Segmental dependent transport of low permeability compounds along the small intestine due to P-glycoprotein: the role of efflux transport in the oral absorption of BCS class III drugs.
Dahan A; Amidon GL
Mol Pharm; 2009; 6(1):19-28. PubMed ID: 19248230
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
